These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
630 related articles for article (PubMed ID: 16402046)
1. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors. Olianas MC; Concas D; Onali P Br J Pharmacol; 2006 Feb; 147(4):360-70. PubMed ID: 16402046 [TBL] [Abstract][Full Text] [Related]
2. G protein activation and cyclic AMP modulation by naloxone benzoylhydrazone in distinct layers of rat olfactory bulb. Onali P; Olianas MC Br J Pharmacol; 2004 Nov; 143(5):638-48. PubMed ID: 15451772 [TBL] [Abstract][Full Text] [Related]
3. Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors. Bigoni R; Caò G; Rizzi A; Okawa H; Regoli D; Smart D; Lambert DG Can J Physiol Pharmacol; 2002 May; 80(5):407-12. PubMed ID: 12056546 [TBL] [Abstract][Full Text] [Related]
4. N-Desmethylclozapine, a major clozapine metabolite, acts as a selective and efficacious delta-opioid agonist at recombinant and native receptors. Onali P; Olianas MC Neuropsychopharmacology; 2007 Apr; 32(4):773-85. PubMed ID: 16841075 [TBL] [Abstract][Full Text] [Related]
5. Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes. Onali P; Dedoni S; Olianas MC J Pharmacol Exp Ther; 2010 Jan; 332(1):255-65. PubMed ID: 19828880 [TBL] [Abstract][Full Text] [Related]
6. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor. Olianas MC; Maullu C; Onali P Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494 [TBL] [Abstract][Full Text] [Related]
7. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain. Sim LJ; Childers SR J Comp Neurol; 1997 Oct; 386(4):562-72. PubMed ID: 9378852 [TBL] [Abstract][Full Text] [Related]
8. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys. Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881 [TBL] [Abstract][Full Text] [Related]
9. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands. Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330 [TBL] [Abstract][Full Text] [Related]
10. In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated. Ichikawa D; Ozaki S; Azuma T; Nambu H; Kawamoto H; Iwasawa Y; Takeshima H; Ohta H Neuroreport; 2001 Jun; 12(8):1757-61. PubMed ID: 11409754 [TBL] [Abstract][Full Text] [Related]
11. Lack of evidence of kappa2-selective activation of G-proteins: kappa opioid receptor stimulation of [35S] GTPgammaS binding in guinea pig brain. Childers SR; Xiao R; Vogt L; Sim LJ Biochem Pharmacol; 1998 Jul; 56(1):113-20. PubMed ID: 9698095 [TBL] [Abstract][Full Text] [Related]
12. SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors. Xu H; Lu YF; Rice KC; Ananthan S; Rothman RB Brain Res Bull; 2001 Jul; 55(4):507-11. PubMed ID: 11543951 [TBL] [Abstract][Full Text] [Related]
13. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting. Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155 [TBL] [Abstract][Full Text] [Related]
14. 5-HT-stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes. Odagaki Y; Toyoshima R Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):335-45. PubMed ID: 16491386 [TBL] [Abstract][Full Text] [Related]
15. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. Liu JG; Prather PL Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600 [TBL] [Abstract][Full Text] [Related]
16. Binding of GTPgamma[35S] is regulated by GDP and receptor activation. Studies with the nociceptin/orphanin FQ receptor. McDonald J; Lambert DG Br J Pharmacol; 2010 Mar; 159(6):1286-93. PubMed ID: 20148892 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2. Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020 [TBL] [Abstract][Full Text] [Related]
18. Endomorphin-stimulated [35S]GTPgammaS binding in rat brain: evidence for partial agonist activity at mu-opioid receptors. Sim LJ; Liu Q; Childers SR; Selley DE J Neurochem; 1998 Apr; 70(4):1567-76. PubMed ID: 9523574 [TBL] [Abstract][Full Text] [Related]
19. Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors. Ibba M; Kitayama M; McDonald J; Calo G; Guerrini R; Farkas J; Toth G; Lambert DG Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):553-61. PubMed ID: 18807245 [TBL] [Abstract][Full Text] [Related]
20. Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells: functional homology with opioid receptors. Fawzi AB; Zhang H; Weig B; Hawes B; Graziano MP Eur J Pharmacol; 1997 Oct; 336(2-3):233-42. PubMed ID: 9384238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]